Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases
RALEIGH – Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed … Continue reading Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
